JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (2): 61-67.doi: 10.6040/j.issn.1671-7554.0.2016.995
Previous Articles Next Articles
ZHANG Yu, HAN Chen, WANG Zhaoxia, WANG Zhaopeng, ZHANG Yueying, ZHOU Shuping, MA Ranran, WANG Hengxiao
CLC Number:
[1] Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease[J]. World J Gastroenterol, 2014, 20(33): 11684-11699. [2] Ding RB, Tian K, Huang LL, et al. Herbal medicines for the prevention of alcoholic liver disease: a review[J]. J Ethnopharmacology, 2012, 144(3): 457-465. [3] Del Prete A, Scalera A, Iadevaia MD, et al. Herbal products: benefits, limits, and applications in chronic liver disease[J]. Evid Based Complement Alternat Med, 2012: 837939. [4] Zhao L, Peng XJ, Xia PF, et al. Chemical constituents of Tamarix chinensis[J]. Zhong Yao Cai, 2014, 37(1): 61-63. [5] 廖菁, 邢亚超, 李宁, 等. 柽柳属植物的化学成分和药理活性研究进展[J]. 现代药物与临床, 2012, 27(4): 404-408. LIAO Jing, XING Yachao, LI Ning, et al. Advances in studies on chemical constituents in plants of Tamarix L. and their pharmacological activities[J]. Drugs & Clinic, 2012, 27(4): 404-408. [6] Abouzid S, Sleem A. Hepatoprotective and antioxidant activities of Tamarix nilotica flowers[J]. Pharm Biol, 2011, 49(4): 392-395. [7] Assiri AMA. Protective effect of Tamarix amplexicaulis seeds against hepatotoxicity induced by carbon tetrachloride, paracetamol, or D-galactosamine[J]. J Saudi Chem Soc, 2006, 10(3): 437-446. [8] Gross O, Thomas CJ, Guarda G, et al. The inflammasome: an integrated view[J]. Immunol Rev, 2011, 243(1): 136-151. [9] Cui K, Yan G, Xu C, et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1beta in mice[J]. J Hepatol, 2015, 62(6): 1311-1318. [10] DeSantis DA, Ko CW, Liu Y, et al. Alcohol-induced liver injury is modulated by nlrp3 and nlrc4 inflammasomes in mice[J]. Mediators of Inflamm, 2013: 751374. [11] Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity[J]. Nature, 2012, 482(7384): 179-185. [12] 毛竹君, 齐方洲, 熊耀康, 等. 多枝柽柳抗炎、镇痛、抗氧化作用活性部位的筛选[J]. 中国中医药科技, 2013, 20(4): 363-364. [13] Abouzid S, Sleem A. Hepatoprotective and antioxidant activities of Tamarix nilotica flowers[J]. Pharm Biol, 2011, 49(4): 392-395. [14] 陈柳生,梁晓欣,蔡自由,等.柽柳的化学成分研究[J]. 中草药, 2014, 45(13): 1829-1833. CHEN Liusheng, LIANG Xiaoxin, CAI Ziyou, et al. Chemical constituents from Tamarix chinensis[J]. Chinese Traditional and Herbal Drugs, 2014, 45(13): 1829-1833. [15] Ki SH, Park O, Zheng M, et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of tran-scription 3[J]. Hepatology, 2010, 52(4): 1291-1300. [16] 韩琛,王朝霞,贾青,等.蝎毒多肽提取物调控肝脏移植瘤中自然杀伤细胞浸润的机制研究[J]. 中国免疫学杂志, 2016, 32(3): 390-396. HAN Chen, WANG ZhaoXia, JIA Qing, et al. Regulatory mechanism of PESV on tumor-infiltrating natural killer cells in liver orthotopic transplantation tumor[J]. Chin J Immun, 2016, 32(3): 390-396. [17] Bertola A, Mathews S, Ki SH, et al. Mouse model of chronic and binge ethanol feeding(the NIAAA model)[J]. Nat Protoc, 2013, 8(3): 627-637. [18] Zhu H, Jia Z, Misra H. Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence[J]. J Dig Dis, 2012, 13(3): 133-142. [19] Galicia-Moreno M, Gutierrez-Reyes G. The role of oxidative stress in the development of alcoholic liver disease[J]. Rev Gastroenterol Mex, 2014, 79(2): 135-144. [20] Gao L, Zhou Y, Zhong W, et al. Caveolin-1 is essential for protecting against binge drinking-induced liver damage through inhibiting reactive nitrogen species[J]. Hepatology, 2014, 60(2): 687-699. [21] Zintzaras E, Stefanidis I, Santos M, et al. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease[J]. Hepatology, 2006, 43(2): 352-361. [22] Zhou JY, Jiang ZA, Zhao CY, et al. Long term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver[J]. Alcohol Clin Exp Res, 2013, 37(2): 213-222. [23] Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives[J]. J Inflamm Res, 2015, 8: 15-27. [24] Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome 84 activation by regulating NLRP3 expression[J]. J Immunol, 2009, 183(2): 787-791. [25] Wree A, Eguchi A, McGeough MD. NLRP3 inflammasome activation results in hepatocytepyroptosis, liver inflammation and fibrosis[J]. Hepatology, 2014, 59(3): 898-910. |
[1] | ZHANG Luan, CHEN Ou, LUAN Yun, ZHU Xiaobo, CHEN Yuan, WANG Yibiao. Effects of gemigliptin on the therapeutic effect and inflammatory factors of monocrotaline-induced pulmonary arterial hypertension in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 19-22. |
[2] | LIU Zhengmei, JIANG qiong, ZHOU Jianjiang, GUAN Zhizhong, ZHAO Yan, XIONG Lin, XIE Yuan. Effect of Helicobacter pylori infection on NLRP3 inflammasome activation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 9-13. |
|